11 Jun

Posted at 16:20h in COVID-19, Risk Management by . .
[wpseo_breadcrumb]

Legal Update Header On June 10, 2021, the Occupational Safety and Health Administration (OSHA) updated its guidance on mitigating and preventing the spread of COVID-19 in the workplace.

The guidance now focuses on protections for unvaccinated and otherwise at-risk employees. OSHA’s update to the guidance reflects the U.S. Centers for Disease Control and Prevention (CDC) guidance for fully vaccinated people. This guidance emphasizes industries noted for prolonged close-contacts like meat processing, manufacturing, seafood, grocery and high-volume retail.

21 May

Posted at 20:02h in COVID-19, Risk Management by . .
[wpseo_breadcrumb]

Legal Update Header On May 18, 2021, the Occupational Safety and Health Administration (OSHA) announced it is reviewing the U.S. Centers for Disease Control and Prevention (CDC) recommendations for fully vaccinated individuals.

OSHA has indicated it will update its Guidance on Mitigating and Preventing the Spread of COVID-19 in the Workplace and their National Emphasis Program for COVID-19 accordingly once the review is complete. Until then, the agency is referring employers to the CDC’s guidance for information on appropriate measures to protect fully vaccinated workers.

29 Apr

Posted at 23:13h in COVID-19, Employee Benefits by . .
[wpseo_breadcrumb]

News Brief header In a joint statement, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have recommended lifting a pause on the distribution of the Johnson & Johnson (J&J) COVID-19 vaccine.

On April 13, the agencies recommended a pause on the J&J one-dose vaccine after reports of six cases of a rare and severe type of blood clot in individuals following administration of the vaccine. Reports of adverse events following the use of the J&J vaccine suggested an increased risk of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS). Nearly all reports of this serious condition, which involves blood clots with low platelets, have been in adult women under the age of 50.

16 Apr

Posted at 17:30h in COVID-19, Risk Management by . .
[wpseo_breadcrumb]

News Brief header In a joint statement, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have called for an immediate halt on the distribution of the Johnson & Johnson (J&J) COVID-19 vaccine.

The CDC’s Advisory Committee on Immunization Practices will meet on Wednesday, April 14, to further review these cases and assess their potential significance. Until that process is complete, the agencies are recommending a pause in the use of the J&J vaccine out of an abundance of caution.